P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 1, 2007, Pages 25-31

  Schrickx, J ^a   Fink Gremmels, J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; IVERMECTIN; OXYTETRACYCLINE; RHODAMINE 123; VALSPODAR; VERLUKAST;

ARTICLE; CELL CULTURE; CELL STRAIN CACO 2; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CACO-2 CELLS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MODELS, BIOLOGICAL; OXYTETRACYCLINE; P-GLYCOPROTEIN;

EID: 33846081034     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00808.x     Document Type: Article

References (37)

1. Amidon, G.L., Lennernas, H., Shah, V.P. & Crison, J.R. (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research, 12, 413-420.
2. Artursson, P., Palm, K. & Luthman, K. (2001) Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advances in Drug Delivery Reviews, 46, 27-43.
3. Ayrton, A. & Morgan, P. (2001) Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica, 31, 469-497.
4. Balayssac, D., Authier, N., Cayre, A. & Coudore, F. (2005) Does inhibition of P-glycoprotein lead to drug-drug interactions? Toxicology Letters, 156, 319-329.
5. von Bergmann, K., Sudhop, T. & Lutjohann, D. (2005) Cholesterol and plant sterol absorption: recent insights. American Journal of Cardiology, 96, 10D-14D.
6. Calcagno, A.M., Ludwig, J.A., Fostel, J.M., Gottesman, M.M. & Ambudkar, S.V. (2006) Comparison of drug transporter levels in normal colon, colon cancer, and Caco-2 cells: impact on drug disposition and discovery. Molecular Pharmacology, 3, 87-93.
7. Dyer, D.C. (1989) Pharmacokinetics of oxytetracycline in the turkey: evaluation of biliary and urinary excretion. American Journal Veterinary Research, 50, 522-524.
8. Esiobu, N., Armenta, L. & Ike, J. (2002) Antibiotic resistance in soil and water environments. International Journal of Environmental Health Research, 12, 133-144.
9. George, A.M., Davey, M.W. & Mir, A.A. (1996) Functional expression of the humanMDR1gene in Escherichia coli. Archives of Biochemistry and Biophysics, 333, 66-74.
10. Goldstein, L.J., Pastan, I. & Gottesman, M.M. (1992) Multidrug resistance in human cancer. Critical Reviews in Oncology/Hematology, 12, 243-253.
11. Grandi, M. & Giuliani, F.C. (1988) Reduced cytotoxicity of tetracyclines to a multi-drug resistant human cell line. Biochemical Pharmacology, 37, 3038-3041.
12. Griffin, J., Fletcher, N., Clemence, R., Blanchflower, S. & Brayden, D.J. (2005) Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein. Journal Veterinary Pharmacology and Therapeutics, 28, 257-265.
13. Halling-Sorensen, B., Sengelov, G. & Tjornelund, J. (2002) Toxicity of tetracyclines and tetracycline degradation products to environmentally relevant bacteria, including selected tetracycline-resistant bacteria. Archives of Environmental Contamination and Toxicology, 42, 263-271.
14. Hamscher, G., Sczesny, S., Hoper, H. & Nau, H. (2002) Determination of persistent tetracycline residues in soil fertilized with liquid manure by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Analytical Chemistry, 74, 1509-1518.
15. Kaminski, W.E., Piehler, A. & Wenzel J.J. (2006) ABC A-subfamily transporters: structure, function and disease. Biochemical Biophysical Acta, 1762, 510-524.
16. Kartner, N., Evernden-Porelle, D., Bradley, G. & Ling, V. (1985) Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature, 316, 820-823.
17. Kavallaris M., Madafiglio J., Norris M.D. & Haber M. (1993) Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells. Biochemical and Biophysical Research Communications, 190, 79-85.
18. Laffont, C.M. (2002). Factors affecting the disposition of ivermectin in the target species. PhD Thesis, Veterinary Pharmacology, Pharmacy and Toxicology, Utrecht University, Utrecht, The Netherlands.
19. Lau, Y.Y., Wu, C.-Y., Okochi, H. & Benet, L.Z. (2004) Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay. The Journal of Pharmacology and Experimental Therapeutics, 308, 1040-1045.
20. Leonard, G.D., Fojo, T. & Bates, S.E. (2003) The role of ABC transporters in clinical practice. Oncologist, 8, 411-424.
21. Leslie, E.M., Deeley, R.G. & Cole, S.P.C. (2005) Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicology and Applied Pharmacology, 204, 216-237.
22. Lin, J.H. & Yamazaki, M. (2003) Role of P-glycoprotein in pharmacokinetics: clinical implications. Clinical Pharmacokinets, 42, 59-98.
23. Mealey, K.L. (2004) Therapeutic implications of the MDR-1 gene. Journal of Veterinary Pharmacology and Therapeutics, 27, 257-264.
24. Mevius, D.J., Vellenga, L., Breukink, H.J., Nouws, J.F., Vree, T.B. & Driessens, F. (1986) Pharmacokinetics and renal clearance of oxytetracycline in piglets following intravenous and oral administration. Veterinary Quarterly, 8, 274-284.
25. Nielsen, P. & Gyrd-Hansen, N. (1996) Bioavailability of oxytetracycline, tetracycline and chlortetracycline after oral administration to fed and fasted pigs. Journal of Veterinary Pharmacology and Therapeutics, 19, 305-311.
26. Nishimura, M., Yamaguchi, M., Yamauchi, A., Ueda, N. & Naito, S. (2005) Role of soybean oil fat emulsion in the prevention of hepatic xenobiotic transporter mRNA up- and down-regulation induced by overdose of fat-free total parenteral nutrition in infant rats. Drug Metabolism and Pharmacokinetics, 20, 46-54.
27. Ofer, M., Wolffram, S., Koggel, A., Spahn-Langguth, H. & Langguth, P. (2005) Modulation of drug transport by selected flavonoids: involvement of P-gp and OCT? European Journal of Pharmaceutical Sciences, 25, 263-271.
28. Pijpers, A., Schoevers, E.J., Haagsma, N. & Verheijden, J.H. (1991) Plasma levels of oxytetracycline, doxycycline, and minocycline in pigs after oral administration in feed. Journal of Animal Science, 69, 4512-4522.
29. Pouliot, J.-F., L'Heureux, F., Liu, Z., Prichard, R.K. & Georges, E. (1997) Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochemical Pharmacology, 53, 17-25.
30. Scheffer, G.L., Kool, M., Heijn, M., de Haas, M., Pijnenborg, A.C., Wijnholds, J., van Helvoort, A., de Jong, M.C., Hooijberg, J.H., Mol, C.A., van der Linden, M., de Vree, J. M., van der Valk, P., Elferink, R.P., Borst, P. & Scheper, R.J. (2000) Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Research, 60, 5269-5277.
31. Schinkel, A.H. & Jonker, J.W. (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Advanced Drug Delivery Reviews, 55, 3-29.
32. Schinkel, A.H., Wagenaar, E., van Deemter, L., Mol, C.A. & Borst, P. (1995) Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Journal Clinical Investigations, 96, 1698-1705.
33. Thiele-Bruhn, S. (2003) Pharmaceutical antibiotic compounds in soils - a review. Journal of Plant Nutrition and Soils Science, 166, 145-167.
34. Tongaree, S., Flanagan, D.R. & Poust, R.I. (1999) The effects of pH and mixed solvent systems on the solubility of oxytetracycline. Pharmacy Development Technology, 4, 571-580.
35. Welling, P.G. & Tse, F.L. (1982) The influence of food on the absorption of antimicrobial agents. Journal of Antimicrobial Chemotherapy, 9, 7-27.
36. Wu, C.-Y. & Benet, L.Z. (2005) Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharmaceutical Research, 22, 11-23.
37. Yamashita, S., Tanaka, Y., Endoh, Y., Taki, Y., Sakane, T., Nadai, T. & Sezaki, H. (1997) Analysis of drug permeation across Caco-2 monolayer: implication for predicting in vivo drug absorption. Pharmaceutical Research, 14, 486-491.